American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 501–600 of 1,001
Glycemic Management in Medical and Surgical Patients in the Non-ICU Setting
Hawkins, K., Donihi, A. C., & Korytkowski, M. T. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0340-1 · Cited by 17
Self-citationSystemic inflammation in the elderly
Koo, E. G. Y., Lai, L. M. L., Choi, G. Y. S., & Chan, M. T. V. (2011) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2011.06.005 · Cited by 17
A Primer for Achieving Glycemic Control in the Cardiac Surgical Patient
McDonnell, M. E., Alexanian, S. M., White, L. H., & Lazar, H. L. (2012) · Journal of Cardiac Surgery · doi:10.1111/j.1540-8191.2012.01471.x · Cited by 17
Amor, A. J., Ríos, P., Graupera, I., Conget, I., Esmatjes, E., Comallonga, T., & Vidal, J. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.01.037 · Cited by 17
“No obstante, los pacientes de la FI tuvieron mayor edad (media [DE] de 71,9 [5,13] frente a 65,5 [4,11] años; p = 0,047) y estaban en mayor proporción con antidiabéticos orales como único tratamiento de la DM (76,8 frente a 39,1%; p < 0,001).”
BackgroundDiabetes - Damages and Treatments
Rigobelo, E. C. (2011) · InTech eBooks · doi:10.5772/1823 · Cited by 17
Perez, A., Carrasco-Sánchez, F. J., González, C., Seguí-Ripoll, J. M., Trescolí, C., Ena, J., Borrell, M., & Gomez Huelgas, R. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001518 · Cited by 16
Olinghouse, C. (2012) · The Permanente Journal · doi:10.7812/tpp/12.959 · Cited by 16
Levy, N., El‐Boghdadly, K., Lobo, D. N., Stubbs, D. J., Avari, P., Buggy, D. J., Frank, C. B., Howson, K., Moffett, J., Morris, E., et al. (2026) · Anaesthesia · doi:10.1111/anae.70181 · Cited by 17
Kumar, S. S., Pelletier, S. J., Shanks, A. M., Leis, A. M., Sonnenday, C. J., & Picton, P. (2020) · BMC Anesthesiology · doi:10.1186/s12871-019-0918-0 · Cited by 16
Olsen, M. T., Klarskov, C. K., Hansen, K. B., Pedersen‐Bjergaard, U., & Kristensen, P. L. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108803 · Cited by 16
In-patient management of diabetes: Controversies and guidelines
Korytkowski, M. T. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.123554 · Cited by 16
Self-citationSpontaneous and iatrogenic hypoglycaemia related to mortality in the ICU
Cichosz, S. L., Redke, F., & Hejlesen, O. K. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.001 · Cited by 16
Weinberg, L., Lee, D. K., Koshy, A. N., Leong, K. W., Tosif, S. H., Shaylor, R., Pillai, P., Miles, L. F., Drucker, A., & Pearce, B. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.05.002 · Cited by 16
Cardona, S., TSEGKA, K. G., Pasquel, F. J., Jacobs, S., Halkos, M. E., Keeling, W. B., Davis, G. M., Fayfman, M., Albury, B. S., Urrutia, M. A., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14241 · Cited by 16
“Clinical guidelines from professional organizations recommend the use of insulin to manage perioperative hyperglycaemia in cardiac surgery patients.(23,24) Although effective in improving glycaemic control,(10,11) its use is labour intensive and is associated with a higher risk of hypoglycaemia,(13,14) which has been…”
BackgroundSelf-citationSong, S., Zhang, S., Wang, Z., Wang, S., Ma, Y., Ma, P., Luo, H., Wang, M., & Jin, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.640529 · Cited by 16
Huang, W., Whitelaw, J., Kishore, K., Neto, A. S., Holmes, N. E., Marhoon, N., Bellomo, R., & Ekinci, E. I. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108052 · Cited by 16
Lin, L., Lin, Y., Peng, Y., Huang, X., Zhang, X., Chen, L., & Li, S. (2022) · International Heart Journal · doi:10.1536/ihj.21-485 · Cited by 16
Marelli, G., Avanzini, F., Iacuitti, G., Planca, E., Frigerio, I., Busi, G., Carlino, L., Cortesi, L., Roncaglioni, M. C., & Riva, E. (2015) · Journal of Diabetes Research · doi:10.1155/2015/173956 · Cited by 17
“) insulin in non-critically ill patients as first-choice pharmacological treatment to ensure the best possible glycemic control, combined with an appropriate nutrition scheme [1–5].”
BackgroundInfluentialWallia, A., Gupta, S., Garcia, C., Schmidt, K., Oakes, D. J., Aleppo, G., Glossop, V., Andrei, A., Grady, K. L., McGee, E. C., et al. (2013) · Endocrine Practice · doi:10.4158/ep13354.or · Cited by 16
Quality Indicators and Performance Measures in Diabetes Care
Aron, D. C. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0472-y · Cited by 16
Insulin Bolus Calculator in a Pediatric Hospital: Safety and User Perceptions
Ateya, M., Aiyagari, R. M., Moran, C., & Singer, K. (2017) · Applied Clinical Informatics · doi:10.4338/aci-2016-11-ra-0187 · Cited by 16
“Intravenous insulin is the main treatment option for critically-ill patients while scheduled subcutaneous insulin is the preferred option for patients outside the intensive care unit (ICU) [1].”
BackgroundMethodInfluentialFuentes, B., Cuesta, B., Gutiérrez‐Fernández, M., Martínez‐Sánchez, P., Lisbona, A., Madero-Jarabo, R., Delgado‐Mederos, R., Gállego-Culleré, J., Rodríguez‐Yáñez, M., Martínez-Zabaleta, M., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13354 · Cited by 16
“In our study, local protocols were updated according to the guidelines for glucose management in hospitalized patients [10], and only one patient (4.”
BackgroundMethodInfluentialAmbrus, D. B., & O’Connor, M. J. (2018) · Journal of Hospital Medicine · doi:10.12788/jhm.3109 · Cited by 16
Microplegia vs 4:1 Blood Cardioplegia: Effectiveness and Cost Savings in Complex Cardiac Operations
Borden, R., Ball, C., Grady, P. M., Toth, A. J., Lober, C., Bakaeen, F. G., Tong, M. Z.-Y., Soltesz, E. G., Blackstone, E. H., & Roselli, E. E. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.02.006 · Cited by 16
Knowledge, Attitudes, and Decision Making in Hospital Glycemic Management: are Faculty up to Speed?
Pichardo-Lowden, A. R., Kong, L., & Haidet, P. (2015) · Endocrine Practice · doi:10.4158/ep14246.or · Cited by 16
Effect of online diabetes training for hospitalists on inpatient glycaemia
Tamler, R., Dunn, A. S., Green, D. E., Skamagas, M., Breen, T. L., Looker, H. C., & LeRoith, D. (2013) · Diabetic Medicine · doi:10.1111/dme.12151 · Cited by 16
Insulin Infusion Therapy in Critically Ill Patients
Boutin, J., & Gauthier, L. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.01.016 · Cited by 17
Mansur, A., Popov, A., Abu–Hanna, A., Bergmann, I., Brandes, I. F., Beißbarth, T., Bauer, M., & Hinz, J. M. (2015) · Medicine · doi:10.1097/md.0000000000002035 · Cited by 16
Kindlovits, R., Sousa, A., Viana, J. L., Milheiro, J., Oliveira, B. M. P. M., Marques, F., Santos, A., & Teixeira, V. H. (2024) · Nutrients · doi:10.3390/nu16111624 · Cited by 15
“Both diets emphasized low-glycemic-index foods to convey conventional dietary guidelines [37].”
BackgroundAlawaji, R., Musslem, M. T., Alshalahi, E., Alanzan, A., Sufyani, A. M., Alhati, M. M., Almutairi, A., Alqaffas, M., Alattas, B. A., & Alselmi, A. A. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01459-w · Cited by 15
Bhalodkar, A., Sonmez, H., LESSER, M. L., Leung, T., Ziskovich, K., Inlall, D., Murray-Bachmann, R., Krymskaya, M., & Poretsky, L. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0261 · Cited by 16
Douin, D. J., Krause, M., Williams, C., Tanabe, K., Fernandez-Bustamante, A., Quaye, A., Ginde, A. A., & Bartels, K. (2021) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/10892532211043313 · Cited by 15
“002 Days with glucose <80 or >180 mg/dL 6 (2-17) 12 (4-18) 5 (1-14) .”
InfluentialKim, S., Park, J., Kim, H., Yang, K., Choi, J.-H., Kim, K., Sung, J., Ahn, J., & Lee, S. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225219 · Cited by 15
Logical empiricism in anesthesia: A step forward in modern day clinical practice
Bajwa, S. J., & Kalra, S. (2013) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/joacp_2013292_160 · Cited by 15
Cisuelo, O., Stokes, K., Oronti, I. B., Haleem, M. S., Barber, T. M., Weickert, M. O., Pecchia, L., & Hattersley, J. G. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067899 · Cited by 15
Diabetesmanagement im Krankenhaus (Update 2023)
Mader, J. K., Brix, J. M., Aberer, F., Vonbank, A., Resl, M., Hochfellner, D. A., Ress, C., Pieber, T. R., Stechemesser, L., & Sourij, H. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02177-5 · Cited by 15
The Impact of Hyperglycemia on Hematopoietic Cell Transplantation Outcomes: An Integrative Review
Olausson, J. M., Hammer, M. J., & Brady, V. (2014) · Oncology nursing forum · doi:10.1188/14.onf.e302-e312 · Cited by 15
“Hyperglycemia, defined by the American Diabetes Association ([ADA], 2013) as a fasting blood glucose (BG) level of 126 mg/dl or greater or a random glucose of 200 mg/dl or greater, is experienced by a large majority of patients during the acute treatment phase of hematopoietic cell transplantation (HCT) (Hammer et al.…”
BackgroundGulli, G., Frasson, S., Borzì, V., Fontanella, A., Grandi, M., Marengo, C., Nicolucci, A., Pastorelli, R., Solerte, B., Gatti, A., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0585-z · Cited by 15
Smiley, D. D., Umpierrez, G. E., Hermayer, K. L., Newton, C. A., Jacobs, S., Olson, D. E., Khan, A., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.05.007 · Cited by 15
“…surgery in elective surgery patients (McDonnell & Umpierrez, 2012; Smiley & Umpierrez, 2011), or to more medical complications that might have led physicians to choose less stringent targets in the medical patients consistent with recent guidelines (Moghissi et al., 2009; Umpierrez et al., 2012).”
Self-citationAnalysis: Continuous Glucose Monitoring during Intensive Insulin Therapy
Mraović, B. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300444 · Cited by 15
Pasala, S., Dendy, J. A., Chockalingam, V., & Meadows, R. Y. (2013) · Europe PMC (PubMed Central) · Cited by 15
Pichardo-Lowden, A. R., Haidet, P., & Umpierrez, G. E. (2017) · Endocrine Practice · doi:10.4158/ep161634.ra · Cited by 15
“This aligns with current clinical practice recommendations (10,12,67) and supports the notion that education among providers can shift the pendulum towards better achievement of diabetes care beyond hospitalization.”
BackgroundMethodResultInfluentialSelf-citationPoole, A. P., Finnis, M., Anstey, J. R., Bellomo, R., Bihari, S., Biradar, V., Doherty, S., Eastwood, G. M., Finfer, S. R., French, C., et al. (2020) · Critical Care and Resuscitation · doi:10.51893/2020.2.oa3 · Cited by 15
Xie, W., Wu, N., Wang, B., Xu, Y., Zhang, Y., Xiang, Y., Zhang, W., Chen, Z., Yuan, Z., Li, C., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109041 · Cited by 15
Nutrition Considerations for the Growing Population of Older Adults With Diabetes
Stanley, K. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.1.29 · Cited by 15
Forni, A. A., Rocchio, M. A., Szumita, P. M., Anger, K. E., Avery, K. R., & Scirica, B. M. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.01.002 · Cited by 15
Fantin, S. D. S., Wainstein, M. V., Polanczyk, C. A., Ledur, P. D. S., Lazzari, C. M., Klein, C., Hackenhaar, F. S., Benfato, M. S., & Schaan, B. D. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0256 · Cited by 15
“For the majority of noncritically ill patients treated with insulin, premeal glucose targets are recommended to be lower than 140 mg/dl and random glucose values lower than 180 mg/dl, avoiding levels to decline less than 100 mg/dl (18).”
BackgroundElectrochemical Glucose Biosensors for Diabetes Care
Ocvirk, G., Buck, H., & DuVall, S. H. (2016) · Bioanalytical reviews · doi:10.1007/11663_2016_3 · Cited by 16
Determining Current Insulin Pen Use Practices and Errors in the Inpatient Setting
Brown, K. E., & Hertig, J. B. (2016) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(16)30109-x · Cited by 15
Neff, K., Donegan, D. M., MacMahon, J., O'Hanlon, C., Keane, N., Agha, A., Thompson, C. D., & Smith, D. C. (2014) · PubMed · Cited by 15
Acute Hyperglycemia Associated with Short-Term Use of Atypical Antipsychotic Medications
Liao, T. V., & Phan, S. V. (2014) · Drugs · doi:10.1007/s40265-013-0171-7 · Cited by 15
Early diagnostic of diabetic foot using thermal images
Cajacuri, L. A. V. (2013) · theses.fr (ABES) · doi:10.70675/a22bf653zda6fz4a91zbd90z2f11c7afabe4 · Cited by 15
Lim, Y., Ohn, J. H., Jeong, J., Ryu, J., Kim, S.-W., Cho, J. H., Park, H.-S., Kim, H. W., Lee, J., Kim, E. S., et al. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1341 · Cited by 14
Desgrouas, M., Demiselle, J., Stiel, L., Brunot, V., Marnai, R., Sarfati, S., Fiancette, M., Lambiotte, F., Thille, A. W., Leloup, M., et al. (2023) · Annals of Intensive Care · doi:10.1186/s13613-023-01142-9 · Cited by 14
“absolutely avoid low blood glucose levels known to be associated with increased mortality [5-8].”
BackgroundBenchmarking Glucose Results through Automation: The 2009 Remote Automated Laboratory System Report
Anderson, M., Zito, D. R., & Kongable, G. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400627 · Cited by 14
How Sweet Is It? The Use of Benchmarking to Optimize Inpatient Glycemic Control
Maynard, G., Ramos, P., Kulasa, K. M., Rogers, K. M., Messler, J., & Schnipper, J. L. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.212 · Cited by 14
Insulin pumps: Beyond basal-bolus
Millstein, R., Becerra, N. M., & Shubrook, J. H. (2015) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82a.14127 · Cited by 14
Hulst, A. H., Polderman, J. A. W., Kooij, F. O., Vittali, D., Lirk, P. B., Hollmann, M. W., DeVries, J. H., Preckel, B., & Hermanides, J. (2018) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13274 · Cited by 14
Hysterectomy Complications Relative to HbA1c Levels: Identifying a Threshold for Surgical Planning
Ringel, N. E., Morgan, D. M., Kamdar, N. S., & Gutman, R. E. (2021) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2021.02.010 · Cited by 14
Perioperative glucose control: living in uncertain times—Continuing Professional Development
Girard, M., & Schricker, T. (2011) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9449-3 · Cited by 14
Glycemic control in non-critical hospitalized patients
Botella, M., Rubio, J. A., Percovich, J. C., Platero, E., Tasende, C., & Álvarez, J. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.07.008 · Cited by 14
Glycemic Variability and Glycemic Control in the Acutely Ill Cardiac Patient
Moore, J., & Dungan, K. M. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.006 · Cited by 14
Complicaciones asociadas a la hiperglucemia en pacientes trasplantados de hígado
Builes-Montaño, C. E., Escobar, J. F. M., Londoño, C. A., Bayona, K. L. P., Restrepo, J. C., Restrepo, J. G., Toro, C. M. A., & Jaimes, F. A. (2014) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2014.08.002 · Cited by 14
“1 (1-100) Uso de NPT (porcentaje), n (%) 13 (8%)”
Glucose Control in Mayo Clinic Intensive Care Units
Pattan, V., Parsaik, A. K., Brown, J. K., Kudva, Y. C., Vlahakis, N. E., & Basu, A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500613 · Cited by 14
Kirk, J. K., & Oldham, E. C. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m695 · Cited by 14
Li, F.-F., Zhang, W., Liu, B.-L., Zhang, D., Chen, W., Li, Y., Chen, M.-Y., Zhai, X., Wu, J.-D., Su, X., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24275-5 · Cited by 14
van Steen, S. C. J., Rijkenberg, S., van der Voort, P. H. J., & DeVries, J. H. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0507-x · Cited by 14
He, A., Zuo, D., Liang, X., Guo, Y., Suxin, L., & Xia, Y. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104075 · Cited by 14
Emidio, A. C., Faria, B. B. R., Vaz-Pinto, V., Messias, A. M., & Meneses-Oliveira, C. (2021) · Critical Care Science · doi:10.5935/0103-507x.20210015 · Cited by 14
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Lo, C., Toyama, T., Hirakawa, Y., Jun, M., Cass, A., Hawley, C. M., Pilmore, H., Badve, S. V., Perkovic, V., & Zoungas, S. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011798 · Cited by 14
Effect of a Diabetes Curriculum on Internal Medicine Resident Knowledge
Rubin, D. J., & McDonnell, M. E. (2010) · Endocrine Practice · doi:10.4158/ep09275.or · Cited by 14
McCavert, M., Mone, F., Dooher, M., Brown, R., & O’Donnell, M. E. (2010) · International Journal of Surgery · doi:10.1016/j.ijsu.2010.06.017 · Cited by 14
Differentiated Prevention of Cardiac Complications of Extracardiac Surgery
Korniyenko, A., Dobrushina, O. R., & Zinina, E. P. (2011) · General Reanimatology · doi:10.15360/1813-9779-2011-5-57 · Cited by 14
Haines, S. T., Miklich, M. A., & Rochester-Eyeguokan, C. D. (2016) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160416 · Cited by 14
Phillips, V. L., Byrd, A. L., Adeel, S., Peng, L., Smiley, D. D., & Umpierrez, G. E. (2017) · PharmacoEconomics - Open · doi:10.1007/s41669-017-0020-9 · Cited by 13
“Current clinical guidelines now recommend the use of BBI in general surgery patients specifically to help manage diabetes and hyperglycaemia [20, 21].”
BackgroundSelf-citationImpact of structured insulin order sets on inpatient hypoglycemia and glycemic control
Kravchenko, M. I., Tate, J. M., Clerc, P. G., Forbes, W. L., Gettle, M. C., Wardian, J. L., & Colburn, J. A. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0341 · Cited by 13
Demidowich, A. P., Stanback, C., & Zilbermint, M. F. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15190 · Cited by 13
Zenti, M. G., Rubbo, I., Ceradini, G., Rinaldi, E., Nadalini, L., Battistoni, M., Genna, M., Bonora, E., & Zoppini, G. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0738-8 · Cited by 13
“Diabetes was diagnosed by ADA criteria [14].”
Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
Preckel, B., Schultz, M. J., Vlaar, A. P. J., Hulst, A. H., Hermanides, J., de Jong, M. D., Schlack, W. S., Stevens, M. F., Weenink, R. P., & Hollmann, M. W. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051495 · Cited by 13
“Therefore, adherence to current guidelines on glycaemic control strategies seems most prudent and logical (including frequent monitoring and administering intravenous insulin with a glucose target range of at least <180 mg/dL) [88].”
BackgroundSardu, C., Paolisso, P., Ducceschi, V., Santamaria, M., Sacra, C., Massetti, M., Ruocco, A., & Marfella, R. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01180-8 · Cited by 13
Das, S., Rastogi, A., Harikumar, K. V. S., Dutta, D., Sahay, R. K., Kalra, S., Ghosh, S. K., Gupta, S. K., Pandit, K., Jabbar, P. K., et al. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_227_21 · Cited by 13
Diretriz BRASPEN de Terapia Nutricional no Diabetes Mellitus
Campos, L. F., Borges, V. C., Barreto, P. A., González, M. C., Ceniccola, G. D., de Abreu, H. B., Alves, J. T. M., Segadilha, N. L. A. L., Kumbier, M. C. C., & Castro, M. G. (2020) · Braspen Journal · doi:10.37111/braspenj.diretrizdm2020 · Cited by 13
Teotia, K., Jia, Y., Woite, N. L., Celi, L. A., de Matos, J. C. R. G., & Struja, T. (2024) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2024.104643 · Cited by 13
Management of the Hospitalized Patient With Type I Diabetes Mellitus
Mendez, C. E., & Umpierrez, G. E. (2013) · Hospital Practice · doi:10.3810/hp.2013.08.1072 · Cited by 13
Self-citationImpact of a multifaceted strategy to improve perioperative diabetes care
Hommel, I., Wollersheim, H. C. H., Tack, C. J., Mulder, J., van Gurp, P. J. M., & Hulscher, M. (2016) · Diabetic Medicine · doi:10.1111/dme.13130 · Cited by 13
Management of hospitalized type 2 diabetes mellitus patients
Marín-Peñalver, J. J., Timon, I. M., & del Cañizo-Gómez, F. J. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0027 · Cited by 13
Rogers, M. A. M., Lin, P., Nallamothu, B. K., Kim, C., & Waljee, A. K. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12631 · Cited by 13
Building a Business case for Inpatient Diabetes Management Teams: Lessons from our Center
Sidhaye, A. R., Mathioudakis, N. N., Bashura, H., Sarkar, S., Zilbermint, M. F., & Golden, S. H. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0471 · Cited by 13
Perioperative glycemic control and its outcome in patients following open heart surgery
Siddiqui, K. M., Asghar, M. A., Khan, M. F., & Khan, F. H. (2019) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_82_18 · Cited by 13
“Based on recent information, the new Society of Thoracic Surgeons guidelines and the American Association of Clinical Endocrinologists and American Diabetes Association (AACE/ADA) consensus statement seem appropriate and allay the concern for hypoglycemia with the new recommended range of <180 and 140–180 mg/dl.[31] M…”
BackgroundDiabetic patients with COVID-19 need more attention and better glycemic control
Xu, M. J., Yang, W. T., Huang, T., & Zhou, J. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i12.644 · Cited by 13
Cimini, F. A., Barchetta, I., Zuliani, I., Pagnotta, S. E., Bertoccini, L., Dule, S., Zampieri, M., Reale, A., Baroni, M. G., Cavallo, M. G., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119913 · Cited by 13
Control de la glucemia en el paciente crítico
García‐Acuña, J. M., & Assi, E. A. (2015) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(15)30026-1 · Cited by 13
Nutrition Support Team‐Led Glycemic Control Program for Critically Ill Patients
Dickerson, R. N., Maish, G. O., Minard, G., & Brown, R. O. (2014) · Nutrition in Clinical Practice · doi:10.1177/0884533614530763 · Cited by 13
Improvement in Inpatient Glycemic Care: Pathways to Quality
Aloi, J., Mulla, C. M., Ullal, J., & Lieb, D. C. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0587-4 · Cited by 13
Gómez‐Huelgas, R., Lopez-Carmona, M. D., Jansen‐Chaparro, S., Sobrino, B., Chaves, M., Martin-Gallardo, P., Garcia-Fernandez, C., & Bernal-López, M. R. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0520-8 · Cited by 13
“The current guidelines [3, 6, 8, 9] advise against the use of oral agents in inpatients with diabetes because of their limited usefulness and safety in this setting.”
BackgroundMethodHiggs, M., & Fernandez, R. S. (2015) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2015-1911 · Cited by 13
Choi, H. Y., Kim, Y. H., Kim, M. J., Lee, S. H., Bang, K., Han, S. Y., Lim, H.-S., & Bae, K. (2014) · Drugs in R&D · doi:10.1007/s40268-014-0054-8 · Cited by 14
“0 % as monotherapies, but many patients eventually require combination therapy [30, 31].”
BackgroundAllende-Vigo, M. Z., González-Rosario, R. A., González, L., Sánchez, V. M., Vega, M., Alvarado, M., & Ramón, R. O. (2013) · Endocrine Practice · doi:10.4158/ep13199.or · Cited by 13
Joseph, J. I., Torjman, M. C., & Strasma, P. J. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815587938 · Cited by 13
“A nurse must obtain a blood sample and BG measurement prior to adjusting insulin therapy.(38-45) Clinical trials are under way to evaluate whether a clinical nurse can use the subcutaneous tissue CGMS trend data to maintain a hospitalized patient’s BG concentration in the target range, eliminate hypoglycemia, and impr…”
BackgroundMethodHyperglycemia And Hypoglycemia In Patients With Diabetes In Skilled Nursing Facilities
Patell, R. D., Nigmatoulline, D., Bena, J., Kim, D., Messinger‐Rapport, B. J., & Lansang, M. C. (2017) · Endocrine Practice · doi:10.4158/ep161502.or · Cited by 13
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.